Development of RUNX1-CBFB interaction inhibitor for RUNX1-dependent leukemias

Taishi Yonezawa

Presentation information

Oral Session

Oral Session 1-11C AML: Pathophysiology (1)

Fri. Oct 11, 2019 3:20 PM - 4:20 PM No.11 (Tokyo International Forum, 5F G502)

Chair: Yoichi Imai (Department of Hematology/Oncology, IMSUT Hospital, The University of Tokyo)

[OS1-11C-2] Development of RUNX1-CBFB interaction inhibitor for RUNX1-dependent leukemias

Taishi Yonezawa¹, Hirotaka Takahashi², Tatsuya Sawasaki², Toshio Kitamura¹, Susumu Goyama¹ (1.The institute of Medical Science., Tokyo Univ., Tokyo, Japan, 2.Proteo-Science Center (PROS)., Ehime University., Ehime, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.